Elagolix Reduces Productivity Losses in Uterine Fibroids Patients with Heavy Menstrual Bleeding
ACOG ePoster. Diamond M. Apr 27, 2018; 211885; 33G
Michael Diamond
Michael Diamond
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Rate & Comment (0)
Introduction: This study assessed the impact of elagolix, an oral gonadotropin-releasing hormone antagonist, on workplace productivity in uterine fibroids (UF) patients with heavy menstrual bleeding (HMB).

Methods: M12-813 was a Phase IIb, randomized, double-blind, placebo-controlled trial with 6-month treatment period in premenopausal UF patients with HMB (80 mL menstrual blood loss per month). M12-813 had two cohorts: elagolix 300mg twice daily (cohort 1) and elagolix 600mg once daily (cohort 2). Each cohort had four arms: placebo, elagolix alone, and two elagolix plus add-back arms (low dose [LDA]: estradiol [E2] 0.5mg/norethindrone acetate [NETA] 0.1mg and standard dose [SDA]: 1.0mg E2/0.5mg NETA). UF-related workplace productivity hours lost to absenteeism and presenteeism (reduced productivity while at work) were measured at baseline and month 6 using the health-related productivity questionnaire. Changes from baseline were compared between elagolix arms and placebo utilizing analysis of covariance.

Results: Cohort 1 included 204 women. At month 6, larger reductions in least-squared (LS) mean hours lost due to absenteeism were observed for elagolix 300mg BID, elagolix 300mg BID+LDA and elagolix 300mg BID+SDA (LS Means: -2.2, -2.6, and - 2.6 hours, respectively) compared to placebo (LS Means:-1.0 hours). P-values were
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Save Settings